Targeting transcription of MCL-1 sensitizes HER2-amplified breast cancers to HER2 inhibitors

Human epidermal growth factor receptor 2 gene (HER2) is focally amplified in approximately 20% of breast cancers. HER2 inhibitors alone are not effective, and sensitizing agents will be necessary to move away from a reliance on heavily toxic chemotherapeutics. We recently demonstrated that the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Floros, Konstantinos V., Jacob, Sheeba, Kurupi, Richard, Fairchild, Carter K., Hu, Bin, Puchalapalli, Madhavi, E. Koblinski, Jennifer, Dozmorov, Mikhail G., Boikos, Sosipatros A., Scaltriti, Maurizio, Faber, Anthony C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884408/
https://www.ncbi.nlm.nih.gov/pubmed/33589591
http://dx.doi.org/10.1038/s41419-021-03457-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884408/
https://www.ncbi.nlm.nih.gov/pubmed/33589591
http://dx.doi.org/10.1038/s41419-021-03457-6

Ejemplares similares